Pfizer was approved by the FDA for their first gene therapy for rare bleeding disorder

Food and Drug Administration

agency of the US Department of Health and Human Services Pfizer

American multinational pharmaceutical corporation

MSNBC

Apr 26, 2024, 1:28 PM

Source

FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder

The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.

CNBC

Apr 26, 2024, 11:02 AM

Source

FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder

The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.

Opinions

You've reached the end